Diabetes Medication

|

13

Novo Nordisk Seeks U.S. FDA Approval for Oral Type 2 Diabetes Medication

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

|

Diabetes drug effective against heart failure in wide spectrum of patients

The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with …

Two Type 2 Diabetes Drugs Linked to Higher Risk of Heart Disease

Two drugs commonly prescribed to treat type 2 diabetes carry a high risk of cardiovascular events such as heart attack, stroke, heart failure or …

|

Diabetes Drug Prevents Heart Failure; Kidney Risks

In the largest trial of its kind to determine the cardiovascular outcomes for a new class of diabetes medications, Astra Zeneca’s Farxiga was …

Lilly’s Trulicity® Shows Reduction of Cardiovascular Events for Broad Range of People with Type 2 Diabetes

Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of …

Researchers Find Ways to Prevent Heart Disease in Type 1 Diabetes

Metformin, a commonly prescribed drug for type 2 diabetes could prevent heart disease in patients with type 1 diabetes -and could lead to the …

Lilly’s Investigational Two-in-One Diabetes Drug Shows Positive Results

Eli Lilly and Company’s investigational two-in-one diabetes drug showed both meaningful blood sugar reduction and significant weight loss in …

Weight Loss Drug Shows Positive Effect on Diabetes

A weight loss drug, lorcaserin, was found to reduce the risk of diabetes by 19 percent in patients with prediabetes in a recent study. The drug is …

Tresiba® for Children with Type 1 diabetes Approved in Canada

Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada. …

ADA Spotlight: Should Metformin Remain the First-Line Therapy for Type 2 Diabetes?

Should metformin remain first-line therapy for type 2 diabetes?  It was one of the more light-hearted but hotly-debated presentations at this …

| |